Analyst Tycho Peterson of Jefferies maintained a Buy rating on Thermo Fisher (TMO – Research Report), reducing the price target to $560.00.
Tycho Peterson has given his Buy rating due to a combination of factors including Thermo Fisher’s strategic mitigation efforts and potential upside despite current challenges. The company is facing headwinds from China tariffs and U.S. policy changes, which have impacted revenue and earnings per share (EPS). However, Thermo Fisher is actively working on mitigating these impacts through supply chain adjustments and cost management, which are expected to stabilize earnings in the long run.
Moreover, the company’s core growth, although revised downwards, still shows resilience, particularly in the biotech sector where new programs are driving interest and success. The potential easing of China tensions could also provide a positive shift, offering further growth opportunities. These factors, combined with favorable pricing and foreign exchange benefits, contribute to the Buy rating as the company is positioned to navigate through the current economic challenges effectively.
In another report released today, Stifel Nicolaus also maintained a Buy rating on the stock with a $620.00 price target.
Based on the recent corporate insider activity of 93 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TMO in relation to earlier this year.